arrow
M

Massimiliano Garzaro

azienda ospedaliero-universitaria san luigi gonzaga
H指数:28
被引数:2,589

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial

美泊利单抗对意大利严重、未控制的伴有鼻息肉的慢性鼻窦炎患者的疗效(MEPOREAL):一项真实世界、多中心、IV期试验

2026-08-180
PRE
Switching to dupilumab from other biologic therapies in chronic rhinosinusitis with nasal polyps (CRSWNP): a comparison with biologic-naïve patients

从其他生物制剂疗法转换为度普利尤单抗治疗慢性鼻窦炎伴鼻息肉(CRSWNP):与生物制剂初治患者的比较

2026-08-010
PRE
DUPILUMAB-INDUCED BLOOD EOSINOPHILIA IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: TEMPORAL TRENDS AND CORRELATION WITH ADVERSE EVENTS.

度普利尤单抗诱导的慢性鼻窦炎伴鼻息肉患者血嗜酸性粒细胞增多:时间趋势及与不良事件的关联。

2025-10-310
PRE
Two-Year Turning Point With Dupilumab in CRSwNP: Control, Remission, and Tapering Dosage

Dupilumab治疗CRSwNP的两年转折点:控制、缓解和减量给药

2025-08-300
PRE
Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)

多学科决策-经过两年的实际实践,通过生物制剂 (ITACA研究) 管理严重不受控制的CRSwNP的意大利共识

2024-03-122
PRE
Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice

慢性鼻-鼻窦炎伴鼻息肉:临床实践中疾病控制的常规管理与评估调查

2023-10-264
OA
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL)

Dupilumab治疗严重的不受控制的慢性鼻窦炎伴鼻息肉 (CRSwNP): 一项多中心观察性IV期现实生活研究 (DUPIREAL)

2023-05-2658
OA
Survey on Use of Local and Systemic Corticosteroids in the Management of Chronic Rhinosinusitis with Nasal Polyps: Identification of Unmet Clinical Needs
2022-05-2930
OAAI
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients
2020-11-2692
OAAI